Maslan Andrew Scott 4
4 · CYTOMEDIX INC · Filed Oct 17, 2011
Insider Transaction Report
Form 4
CYTOMEDIX INCCMXI
Maslan Andrew Scott
Chief Financial Officer
Transactions
- Other
Common Stock
2011-10-17+475→ 69,665 total
Footnotes (1)
- [F1]Received pursuant to a stock dividend as the Company's outstanding Series D Convertible Preferred Stock.